AVUV vs AVDV: U.S. vs International Small-Cap Value ETFs

If you searched “AVUV vs AVDV,” you probably want one thing: are these two funds alternatives, complements, or the same bet in two wrappers? Here is the short answer.

Expense ratios and benchmarks as of January 1, 2026, from the AVUV and AVDV fund pages.

AVUV vs AVDV: the simple difference

The whole difference is geography. AVUV buys U.S. small-cap value stocks. AVDV buys small-cap value stocks in developed markets outside the U.S., with its largest country weights in Japan, Canada, the U.K., and Australia. AVUV is benchmarked to the Russell 2000 Value index; AVDV is benchmarked to MSCI World ex USA Small Cap. They sit in different parts of your portfolio: AVUV tilts your U.S. sleeve, AVDV tilts your international sleeve.

Because AVDV invests abroad, it carries risks AVUV does not: currency movements, country and political risk, and different sector and country composition. It also costs more, 0.36% versus 0.25%, which is normal for international small-cap strategies because foreign small caps are more expensive to research and trade. Over long stretches the two funds will diverge. U.S. and non-U.S. small value do not move together, so one can lead while the other lags for years. That divergence is the reason to consider owning both: it spreads the source of the tilt across regions rather than betting it all on one.

Why they are similar: the Avantis method

AVUV and AVDV run the same playbook in different markets. Avantis describes its approach as systematic and active, aiming for the benefits of indexing (broad diversification, low turnover, transparency) while still using current prices and company financials to decide what to overweight. An index fund rebalances once or twice a year on stale data; Avantis trades daily on up-to-date information and spreads trades through the year to keep costs down.

The factor logic comes straight from that paper. Avantis ranks companies on two ratios at once: book equity to price (the value signal) and cash-based profits to book equity (the profitability signal). The reasoning is that a low price alone does not tell you whether a stock is cheap or simply deserves to be cheap. A low price paired with healthy profitability points to a higher expected return; a low price paired with weak profitability often points to a value trap. Avantis also leans away from companies with aggressive asset growth and low profitability, and it manages momentum through patient trading rather than chasing it. The result is meant to be small, cheap, and profitable, while avoiding the junk that drags raw small-cap baskets down.

One caveat: the Avantis paper is a philosophy and process document, not the exact portfolio algorithm. AVUV and AVDV are consistent with that framework, but you cannot reconstruct either fund’s precise holdings from the PDF. Treat it as the why, not a recipe.

Why not both AVUV and AVDV?

For many factor investors, owning both is the coherent choice. If your portfolio already holds U.S. and international stocks, then applying the same small-value tilt to each sleeve, AVUV on the U.S. side and AVDV on the international side, keeps the tilt global instead of making it a U.S.-only bet. The international value evidence is, if anything, stronger for small caps than for large.

Owning both is not automatically better, though. Each fund you add is another position to rebalance, another line item that can lag the S&P 500 for years, and another source of the behavioral pressure that makes people abandon factor tilts at the worst time. AVDV also layers on currency and country risk. “Both” makes sense if you want a deliberate, sized, global tilt and can sit through long stretches of underperformance. It does not make sense if you are reaching for complexity you will not hold onto.

Where AVES fits with AVUV and AVDV

The natural next question is emerging markets. AVES is the Avantis Emerging Markets Value ETF, and it is the emerging-markets leg of a global value tilt. One distinction matters: AVES is not the emerging-markets version of AVUV and AVDV. AVUV and AVDV are specifically small-cap value funds. AVES invests in emerging-markets value companies across all market caps, large, mid, and small. So the clean way to picture the three is:

AVES is benchmarked to the MSCI Emerging Markets IMI Value index, with top country weights in China, Taiwan, India, South Korea, and Brazil. See the AVES fund page.

For a global factor tilt, AVES is a logical complement: AVUV tilts the U.S. sleeve, AVDV tilts the developed-international small-cap sleeve, and AVES tilts the emerging-markets sleeve. All three express the same Avantis philosophy of favoring lower valuations and higher profitability. AVES also adds risks the other two do not carry as much of: political, governance, currency, liquidity, and country concentration. It is not necessary for everyone. If you already own a broad international index fund you have some emerging-markets exposure, and if you own AVGV you already hold AVES inside it. Adding AVES on top of AVGV is a deliberate decision to overweight emerging-markets value, not a way to complete the set.

How AVUV and AVDV relate to AVGV

AVGV is the Avantis All Equity Markets Value ETF, a fund-of-funds that holds other Avantis ETFs underneath. Relative to a total-market fund like VT, AVGV is genuinely tilted toward value and toward smaller companies. The nuance, and the reason this matters for the AVUV vs AVDV question, is what sits inside it. As of mid-2026, AVGV is roughly 37% AVLV (U.S. large value), 18% AVUV, 17% AVIV (international large value), 10% AVES, 9% AVDV, and 7% AVMV (U.S. mid value).

So AVGV already gives you a partial AVUV and AVDV position. Owning a share of AVGV is roughly 18 cents of AVUV and 9 cents of AVDV on the dollar, with the rest in large value, mid value, and emerging-markets value. That is a real small-value tilt, but it is a diluted one. If you want a stronger small-cap value tilt than AVGV delivers on its own, adding direct AVUV and AVDV is how you get there. The exposures stack, which is fine when it is intentional. The calculator below shows exactly how much you end up with.

AVUV and AVDV vs the Dimensional funds (DFSV, DISV)

Dimensional and Avantis are close cousins, not opposites. Both are systematic, evidence-based, broadly diversified managers built on the same research: size, relative price, and profitability, implemented with patient, cost-aware trading. The Avantis founders came out of Dimensional, and it shows in the philosophy. DFSV is Dimensional’s U.S. small-cap value ETF and DISV is its international small-cap value ETF, the direct analogs to AVUV and AVDV.

The practical differences are fees and construction details, not philosophy. AVUV at 0.25% is currently cheaper than DFSV at 0.30%, and AVDV at 0.36% is cheaper than DISV at 0.42%. For an investor starting today I lean Avantis on these two sleeves for the lower fees and the very explicit factor framing, but DFSV and DISV are credible substitutes, not inferior products. If you already hold the Dimensional funds in a taxable account, switching purely for brand preference is rarely worth the realized gains.

AVUV and AVDV vs Vanguard (VBR, VIOV)

Vanguard’s small-cap value ETFs are cheaper and more index-like. VBR tracks the CRSP U.S. Small Cap Value index at 0.05% with about 840 holdings and a median market cap near $9 billion, which makes it broader and more mid-cap-leaning than many factor investors expect. VIOV tracks the S&P SmallCap 600 Value index at 0.10%, with a smaller median market cap and a value screen based on book-to-price, earnings-to-price, and sales-to-price.

Vanguard gives you cheap small-cap value beta. Avantis and Dimensional try to give you a more refined small-cap value plus profitability implementation, with the profitability screen and trading discipline that a plain index does not apply. Whether that refinement is worth the extra 20 to 30 basis points a year is unknowable in advance. If your priority is the lowest possible cost and the simplest possible product, VBR or VIOV is the better fit. If you want a deeper, more deliberate factor tilt and can tolerate the tracking error, AVUV and AVDV are built for that job.

The academic case

The Fama-French five-factor model is the academic language behind these funds. It explains average returns using market risk, size, value, profitability, and investment. Fama and French (2015) found that adding profitability and investment improved on the older three-factor model, while noting the model struggles most with small stocks that invest aggressively despite low profitability, exactly the junk that Avantis tries to screen out.

The robust finding is specific: small, cheap, profitable companies have historically looked more attractive than small, expensive, unprofitable, high-investment ones. Plain “small beats large” or “cheap beats expensive” versions are weaker than that. Novy-Marx showed that gross profitability predicted returns about as well as book-to-market, and that controlling for profitability improved value strategies. The size premium on its own is more contested: Asness, Frazzini, Israel, Moskowitz, and Pedersen found a more stable size premium once you control for quality, that is, once you strip out the junk. AVUV and AVDV are practical attempts to harvest that combination rather than raw size or raw value alone.

Can you hold the tilt?

A small-value tilt only helps if you hold it. The funds can trail the S&P 500, large-cap growth, plain small-value index funds, and each other for long stretches. From 2010 to roughly 2024, U.S. large-cap growth dominated and small-cap value lagged badly. Both Avantis and Dimensional state plainly that realized premiums can be negative for years. An investor who buys after a good backtest and sells after three bad years gets the pain without the premium, which is the worst possible result. Before deciding between AVUV, AVDV, both, or neither, the real question is how much tracking error you can sit through without capitulating.

Which setup fits you

You can check how strong your actual factor tilt is in Summitward’s portfolio analysis. The factor regression shows your size and value loadings, so you can confirm whether the tilt you intended is the tilt you actually have, after accounting for everything embedded in funds like AVGV.

Frequently Asked Questions

Are AVUV and AVDV the same fund?

No. They share the same Avantis small-cap value and profitability process, but AVUV holds U.S. stocks and AVDV holds developed-market stocks outside the U.S. They cover different geographies and sit in different parts of a portfolio.

Should I own both AVUV and AVDV?

If your portfolio holds both U.S. and international equity and you want a global small-value tilt, owning both is a coherent way to do it. Owning both is not automatically better, though: it adds positions to rebalance, currency and country risk from AVDV, and more chances to abandon the tilt during a long stretch of underperformance. It fits a deliberate, sized, long-term tilt, not a quick complexity grab.

Does AVGV already include AVUV and AVDV?

Yes. AVGV is a fund-of-funds that holds other Avantis ETFs, including roughly 18% AVUV and 9% AVDV as of mid-2026, alongside large value, mid value, and emerging-markets value sleeves. If you own AVGV you already have a partial small-value tilt; adding direct AVUV and AVDV increases it rather than diversifying it.

Is AVDV just AVUV for emerging markets?

No. AVDV covers developed markets outside the U.S., such as Japan, Canada, and the U.K. The emerging-markets fund is AVES, and AVES invests across all market caps rather than only small caps, so it plays a different role than AVUV or AVDV.

Are Avantis funds better than Vanguard’s VBR?

Better depends on the job. AVUV targets the modern factor logic more directly, with a profitability screen and trading discipline that VBR does not apply, but it costs 0.25% versus 0.05% and can lag a cheap index for years. VBR is cheaper, simpler, and broader. Neither is objectively superior; it depends on how much factor refinement you want and how much tracking error you can hold.

Key Takeaways

• AVUV and AVDV are complements, not rivals. AVUV tilts your U.S. sleeve toward small, cheap, profitable companies; AVDV applies the same idea to developed international stocks.
• How much of each you hold matters more than which one you pick. It depends on your U.S. and international split and how strong a small-value tilt you want.
• AVGV already holds some of both. Roughly 18% AVUV and 9% AVDV sit inside it, so check your embedded exposure before stacking more on top.
• AVES is the emerging-markets leg, and it is all-cap. It complements AVUV and AVDV but is not their emerging-markets twin.
• DFA and Vanguard are reasonable alternatives. DFSV and DISV are close substitutes; VBR and VIOV are cheaper, simpler, and milder. The Avantis case is deeper factor targeting at a higher fee.
• Holding through tracking error decides everything. The premium is expected, not guaranteed, and it can be negative for years. A tilt you sell at the bottom is worse than no tilt at all.

Related Guides

• Why I Like AVUV, AVDV, and AVGV: the broader implementation overview, including the Dimensional alternatives and a sample allocation.
• AVGV Review: A One-Ticker Global Value Tilt: the AVGV deep dive, with a calculator comparing AVGV to a DIY basket of its underlying Avantis ETFs.
• The Case for Small-Cap Value: the academic evidence behind the premium these funds target.
• RMW Explained: The Profitability Factor: how Avantis and Dimensional define profitability, and why it matters for small value.
• Fama-French Factor Analysis: the complete SMB, HML, and five-factor framework.
• The Case for Global Equity Diversification: why AVDV and AVES matter as much as AVUV.
• Should You Own Emerging-Market Stocks?: sizing the AVES leg of a global value tilt.